Results 191 to 200 of about 3,155,088 (299)
Machine Learning-Based Calibration and Performance Evaluation of Low-Cost Internet of Things Air Quality Sensors. [PDF]
Taştan M.
europepmc +1 more source
Miniature sensor for two-dimensional magnetic field distributions [PDF]
J.H.J. Fluitman, H W Krabbe
openalex +1 more source
Presurgery 72‐h fasting in GB patients leads to adaptations of plasma lipids and polar metabolites. Fasting reduces lysophosphatidylcholines and increases free fatty acids, shifts triglycerides toward long‐chain TGs and increases branched‐chain amino acids, alpha aminobutyric acid, and uric acid.
Iris Divé+7 more
wiley +1 more source
Correction: Martin et al. The FeetMe<sup>®</sup> Insoles System: Repeatability, Standard Error of Measure, and Responsiveness. <i>Sensors</i> 2024, <i>24</i>, 6043. [PDF]
Martin N, Leboeuf F, Pradon D.
europepmc +1 more source
Patient engagement involves actively including patients in healthcare decisions and research to ensure care and studies align with their needs. This approach improves outcomes, trust, and communication while fostering collaboration between patients and professionals.
Estela Cepeda+3 more
wiley +1 more source
Hybrid Mode Sensor Fusion for Accurate Robot Positioning. [PDF]
Masalskyi V+3 more
europepmc +1 more source
Transcriptome‐wide analysis of circRNA and RBP profiles and their molecular relevance for GBM
CircRNAs are differentially expressed in glioblastoma primary tumors and might serve as therapeutic targets and diagnostic markers. The investigation of circRNA and RNA‐binding proteins (RBPs) interactions shows that distinct RBPs play a role in circRNA biogenesis and function.
Julia Latowska‐Łysiak+14 more
wiley +1 more source
Impact of the Guard Rings on Self-Induced Signal and Leakage Current in Trench-Isolated Low Gain Avalanche Diodes. [PDF]
Lastovicka-Medin G+3 more
europepmc +1 more source
This study investigates an alternative approach to reactivating the oncosuppressor p53 in cancer. A short peptide targeting the association of the two p53 inhibitors, MDM2 and MDM4, induces an otherwise therapeutically active p53 with unique features that promote cell death and potentially reduce toxicity towards proliferating nontumor cells.
Sonia Valentini+10 more
wiley +1 more source